Robert Freedman
Concepts (529)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 69 | 2020 | 414 | 9.330 |
Why?
| Choline | 11 | 2022 | 106 | 4.350 |
Why?
| Nicotinic Agonists | 14 | 2016 | 100 | 3.440 |
Why?
| Receptors, Nicotinic | 34 | 2013 | 274 | 3.440 |
Why?
| Evoked Potentials, Auditory | 35 | 2020 | 171 | 2.860 |
Why?
| Brain | 33 | 2021 | 2371 | 2.750 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 22 | 2016 | 96 | 2.390 |
Why?
| Prenatal Exposure Delayed Effects | 8 | 2021 | 452 | 2.180 |
Why?
| Hippocampus | 27 | 2013 | 693 | 2.080 |
Why?
| Hot Flashes | 7 | 2014 | 72 | 2.040 |
Why?
| Psychotic Disorders | 8 | 2021 | 118 | 2.030 |
Why?
| Psychiatry | 5 | 2018 | 154 | 1.940 |
Why?
| Sensory Gating | 8 | 2020 | 38 | 1.910 |
Why?
| Schizophrenic Psychology | 19 | 2015 | 86 | 1.820 |
Why?
| Periodicals as Topic | 5 | 2018 | 181 | 1.800 |
Why?
| Neural Inhibition | 16 | 2013 | 140 | 1.750 |
Why?
| Pregnancy Complications, Infectious | 4 | 2021 | 288 | 1.670 |
Why?
| Benzylidene Compounds | 7 | 2013 | 17 | 1.640 |
Why?
| Nicotine | 17 | 2013 | 265 | 1.580 |
Why?
| Fetal Development | 8 | 2021 | 248 | 1.420 |
Why?
| Antidepressive Agents | 3 | 2023 | 195 | 1.340 |
Why?
| Chromosomes, Human, Pair 15 | 16 | 2015 | 53 | 1.290 |
Why?
| Attention | 17 | 2020 | 393 | 1.280 |
Why?
| Ketamine | 2 | 2023 | 92 | 1.280 |
Why?
| Pyridines | 7 | 2013 | 425 | 1.280 |
Why?
| Maternal Exposure | 2 | 2019 | 138 | 1.170 |
Why?
| Gestational Age | 5 | 2022 | 760 | 1.100 |
Why?
| Pregnancy | 17 | 2022 | 5520 | 1.030 |
Why?
| Menopause | 4 | 2014 | 271 | 1.010 |
Why?
| Pursuit, Smooth | 8 | 2007 | 16 | 0.980 |
Why?
| Evoked Potentials | 7 | 2020 | 108 | 0.940 |
Why?
| Mental Disorders | 4 | 2021 | 893 | 0.910 |
Why?
| Dietary Supplements | 5 | 2021 | 460 | 0.890 |
Why?
| Child Behavior | 2 | 2016 | 219 | 0.890 |
Why?
| Humans | 118 | 2023 | 114705 | 0.880 |
Why?
| Electroconvulsive Therapy | 1 | 2023 | 8 | 0.860 |
Why?
| Folic Acid | 3 | 2021 | 161 | 0.860 |
Why?
| Acoustic Stimulation | 17 | 2020 | 314 | 0.860 |
Why?
| Body Temperature Regulation | 4 | 2013 | 72 | 0.830 |
Why?
| Prenatal Care | 4 | 2021 | 253 | 0.830 |
Why?
| Infant, Small for Gestational Age | 1 | 2022 | 76 | 0.800 |
Why?
| Reflex, Startle | 3 | 2014 | 57 | 0.790 |
Why?
| Phosphatidylcholines | 3 | 2018 | 133 | 0.770 |
Why?
| Female | 69 | 2022 | 59521 | 0.760 |
Why?
| Child Development | 4 | 2021 | 385 | 0.760 |
Why?
| Micronutrients | 2 | 2021 | 78 | 0.740 |
Why?
| Infant Behavior | 2 | 2020 | 23 | 0.740 |
Why?
| Neurons | 10 | 2019 | 1280 | 0.720 |
Why?
| Smoking | 14 | 2013 | 1383 | 0.710 |
Why?
| Adult | 50 | 2022 | 30553 | 0.680 |
Why?
| Infant, Newborn | 9 | 2022 | 5047 | 0.680 |
Why?
| Prefrontal Cortex | 3 | 2016 | 262 | 0.670 |
Why?
| Auditory Perception | 7 | 2004 | 102 | 0.660 |
Why?
| Hallucinogens | 1 | 2021 | 73 | 0.660 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2018 | 56 | 0.650 |
Why?
| Editorial Policies | 2 | 2018 | 45 | 0.630 |
Why?
| Saccades | 7 | 2007 | 35 | 0.630 |
Why?
| Endophenotypes | 2 | 2015 | 16 | 0.620 |
Why?
| Perceptual Disorders | 3 | 2005 | 20 | 0.620 |
Why?
| Hydrocortisone | 1 | 2020 | 267 | 0.620 |
Why?
| Male | 72 | 2022 | 55607 | 0.610 |
Why?
| C-Reactive Protein | 4 | 2022 | 362 | 0.610 |
Why?
| Nootropic Agents | 2 | 2020 | 27 | 0.600 |
Why?
| Premature Birth | 1 | 2021 | 276 | 0.590 |
Why?
| Electroencephalography | 9 | 2020 | 362 | 0.590 |
Why?
| Depression | 2 | 2023 | 1134 | 0.580 |
Why?
| Antipsychotic Agents | 7 | 2008 | 184 | 0.580 |
Why?
| Betacoronavirus | 1 | 2020 | 250 | 0.560 |
Why?
| Problem Behavior | 1 | 2018 | 86 | 0.560 |
Why?
| Primary Prevention | 1 | 2018 | 172 | 0.530 |
Why?
| Arousal | 6 | 1993 | 152 | 0.520 |
Why?
| Magnetic Resonance Imaging | 11 | 2013 | 3053 | 0.520 |
Why?
| Marijuana Smoking | 1 | 2019 | 224 | 0.520 |
Why?
| Psychological Trauma | 1 | 2016 | 54 | 0.510 |
Why?
| Validation Studies as Topic | 1 | 2015 | 23 | 0.490 |
Why?
| Cognition Disorders | 3 | 2010 | 476 | 0.490 |
Why?
| Afferent Pathways | 3 | 2013 | 42 | 0.490 |
Why?
| Brain Mapping | 4 | 2013 | 524 | 0.480 |
Why?
| Genotype | 9 | 2015 | 1760 | 0.470 |
Why?
| Amygdala | 1 | 2016 | 170 | 0.470 |
Why?
| Cannabis | 1 | 2021 | 384 | 0.460 |
Why?
| Reaction Time | 7 | 2020 | 376 | 0.460 |
Why?
| Aggression | 1 | 2016 | 183 | 0.460 |
Why?
| Teaching | 1 | 2016 | 213 | 0.450 |
Why?
| Sleep Apnea Syndromes | 1 | 2014 | 74 | 0.430 |
Why?
| Mothers | 5 | 2021 | 651 | 0.430 |
Why?
| Phosphorylcholine | 1 | 2013 | 17 | 0.420 |
Why?
| Bungarotoxins | 9 | 2008 | 44 | 0.420 |
Why?
| Double-Blind Method | 6 | 2016 | 1660 | 0.420 |
Why?
| Neuropsychological Tests | 6 | 2016 | 927 | 0.410 |
Why?
| Sleep | 3 | 2014 | 632 | 0.410 |
Why?
| Genetic Linkage | 10 | 2012 | 294 | 0.400 |
Why?
| Autism Spectrum Disorder | 1 | 2016 | 322 | 0.400 |
Why?
| Emotions | 2 | 2016 | 472 | 0.390 |
Why?
| Ocular Motility Disorders | 2 | 2004 | 25 | 0.390 |
Why?
| Middle Aged | 28 | 2016 | 26738 | 0.380 |
Why?
| Neural Pathways | 3 | 2010 | 261 | 0.380 |
Why?
| Gyrus Cinguli | 3 | 2006 | 70 | 0.370 |
Why?
| Cognition | 3 | 2016 | 989 | 0.370 |
Why?
| Interneurons | 5 | 2001 | 97 | 0.360 |
Why?
| Infant | 9 | 2021 | 7964 | 0.350 |
Why?
| Cerebral Cortex | 5 | 2006 | 380 | 0.340 |
Why?
| 5-Hydroxytryptophan | 1 | 2009 | 22 | 0.340 |
Why?
| Dopamine | 7 | 2009 | 236 | 0.340 |
Why?
| Schizotypal Personality Disorder | 2 | 2002 | 8 | 0.330 |
Why?
| Biomedical Research | 1 | 2015 | 585 | 0.330 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2009 | 38 | 0.330 |
Why?
| Fetus | 4 | 2021 | 700 | 0.330 |
Why?
| Sensation Disorders | 2 | 2007 | 31 | 0.330 |
Why?
| Thalamus | 2 | 2007 | 74 | 0.330 |
Why?
| Peer Review, Research | 1 | 2009 | 34 | 0.330 |
Why?
| Cocaine-Related Disorders | 2 | 2001 | 107 | 0.320 |
Why?
| Body Temperature | 2 | 2007 | 208 | 0.310 |
Why?
| Nitric Oxide Synthase | 2 | 2000 | 209 | 0.310 |
Why?
| Writing | 1 | 2009 | 82 | 0.310 |
Why?
| Substance Withdrawal Syndrome | 2 | 2007 | 159 | 0.310 |
Why?
| Neurons, Afferent | 2 | 1999 | 85 | 0.290 |
Why?
| Sensory Aids | 1 | 2007 | 1 | 0.290 |
Why?
| Learning | 2 | 2009 | 350 | 0.280 |
Why?
| Phenotype | 7 | 2018 | 2797 | 0.280 |
Why?
| Miniaturization | 1 | 2007 | 23 | 0.280 |
Why?
| Humidity | 1 | 2007 | 36 | 0.280 |
Why?
| Biomarkers | 3 | 2015 | 3408 | 0.280 |
Why?
| Neostriatum | 1 | 2007 | 29 | 0.280 |
Why?
| Equipment and Supplies | 1 | 2007 | 38 | 0.280 |
Why?
| Internship and Residency | 1 | 2016 | 926 | 0.270 |
Why?
| Sleep, REM | 2 | 2006 | 50 | 0.270 |
Why?
| Contingent Negative Variation | 2 | 2005 | 6 | 0.270 |
Why?
| Pedigree | 8 | 2009 | 460 | 0.270 |
Why?
| Child | 9 | 2021 | 18420 | 0.260 |
Why?
| Genetic Markers | 7 | 2012 | 320 | 0.260 |
Why?
| Acetylcholine | 3 | 2002 | 166 | 0.260 |
Why?
| Child of Impaired Parents | 2 | 1996 | 40 | 0.260 |
Why?
| Ganglionic Stimulants | 1 | 2005 | 10 | 0.260 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2005 | 13 | 0.260 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 10 | 0.260 |
Why?
| Animals | 32 | 2021 | 31709 | 0.250 |
Why?
| Sensation | 3 | 1991 | 44 | 0.250 |
Why?
| Nicotinic Antagonists | 4 | 2008 | 20 | 0.240 |
Why?
| Galvanic Skin Response | 3 | 2013 | 26 | 0.240 |
Why?
| Young Adult | 5 | 2022 | 10471 | 0.240 |
Why?
| Receptors, Cholinergic | 5 | 2009 | 41 | 0.240 |
Why?
| Time Perception | 1 | 2005 | 24 | 0.240 |
Why?
| Cross-Over Studies | 3 | 2016 | 440 | 0.240 |
Why?
| Child, Preschool | 5 | 2021 | 9118 | 0.240 |
Why?
| Eye Movements | 3 | 2013 | 53 | 0.230 |
Why?
| Genetic Predisposition to Disease | 5 | 2013 | 2086 | 0.230 |
Why?
| Image Processing, Computer-Assisted | 4 | 2013 | 685 | 0.230 |
Why?
| Mice, Inbred C3H | 2 | 2001 | 239 | 0.230 |
Why?
| Sleep Deprivation | 1 | 2006 | 167 | 0.230 |
Why?
| Bipolar Disorder | 4 | 2007 | 205 | 0.220 |
Why?
| Pyramidal Cells | 3 | 2003 | 51 | 0.220 |
Why?
| Norepinephrine | 5 | 1992 | 201 | 0.210 |
Why?
| Mice, Inbred DBA | 2 | 2008 | 174 | 0.210 |
Why?
| Promoter Regions, Genetic | 4 | 2003 | 1131 | 0.210 |
Why?
| Homovanillic Acid | 5 | 1990 | 7 | 0.210 |
Why?
| Rats | 16 | 2002 | 4958 | 0.200 |
Why?
| Linkage Disequilibrium | 2 | 2009 | 245 | 0.190 |
Why?
| Publishing | 2 | 2016 | 124 | 0.190 |
Why?
| Hearing Disorders | 1 | 2001 | 10 | 0.190 |
Why?
| Oxygen | 3 | 2013 | 854 | 0.190 |
Why?
| Social Problems | 1 | 2021 | 11 | 0.190 |
Why?
| Reward | 1 | 2023 | 211 | 0.180 |
Why?
| Vitamin D | 2 | 2021 | 341 | 0.180 |
Why?
| Vitamin A | 1 | 2021 | 52 | 0.180 |
Why?
| Phencyclidine | 3 | 1992 | 4 | 0.180 |
Why?
| Fatty Acids, Omega-3 | 2 | 2021 | 122 | 0.180 |
Why?
| Frontal Lobe | 3 | 2006 | 141 | 0.180 |
Why?
| Attention Deficit Disorder with Hyperactivity | 2 | 2004 | 364 | 0.180 |
Why?
| Gene Expression Regulation | 3 | 2015 | 2320 | 0.170 |
Why?
| Sweating | 2 | 2013 | 23 | 0.170 |
Why?
| Clozapine | 3 | 2004 | 19 | 0.170 |
Why?
| Object Attachment | 1 | 2020 | 33 | 0.170 |
Why?
| Vitamins | 1 | 2021 | 151 | 0.170 |
Why?
| Chromosome Mapping | 4 | 2009 | 487 | 0.170 |
Why?
| Rats, Sprague-Dawley | 8 | 2002 | 2218 | 0.170 |
Why?
| Risk Factors | 10 | 2021 | 8632 | 0.170 |
Why?
| Schizophrenia, Childhood | 1 | 1999 | 3 | 0.160 |
Why?
| Pituitary-Adrenal System | 1 | 2020 | 130 | 0.160 |
Why?
| Analysis of Variance | 5 | 2008 | 1226 | 0.160 |
Why?
| Genetic Variation | 3 | 2003 | 870 | 0.160 |
Why?
| Alleles | 5 | 2009 | 789 | 0.160 |
Why?
| Psychiatric Status Rating Scales | 4 | 2005 | 482 | 0.160 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2020 | 164 | 0.160 |
Why?
| Bombesin | 1 | 1999 | 12 | 0.160 |
Why?
| RNA, Messenger | 7 | 2006 | 2553 | 0.160 |
Why?
| Logistic Models | 2 | 2022 | 1841 | 0.160 |
Why?
| Nutritional Status | 1 | 2021 | 287 | 0.160 |
Why?
| Maternal Age | 1 | 2019 | 117 | 0.160 |
Why?
| Psychomotor Performance | 4 | 2005 | 280 | 0.150 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2013 | 44 | 0.150 |
Why?
| Stem Cells | 1 | 2002 | 546 | 0.150 |
Why?
| Catecholamines | 3 | 2002 | 94 | 0.150 |
Why?
| DNA Mutational Analysis | 3 | 2013 | 372 | 0.150 |
Why?
| Reference Values | 6 | 1996 | 743 | 0.150 |
Why?
| History, 21st Century | 1 | 2018 | 159 | 0.150 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2012 | 1880 | 0.150 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2002 | 801 | 0.150 |
Why?
| Dentate Gyrus | 1 | 1997 | 30 | 0.150 |
Why?
| Irritable Mood | 1 | 2018 | 48 | 0.150 |
Why?
| Family | 4 | 2015 | 589 | 0.150 |
Why?
| Dose-Response Relationship, Drug | 4 | 2010 | 1842 | 0.140 |
Why?
| Disease Models, Animal | 7 | 2009 | 3535 | 0.140 |
Why?
| Urinary Tract Infections | 1 | 2019 | 134 | 0.140 |
Why?
| Adolescent | 11 | 2017 | 17853 | 0.140 |
Why?
| Postmortem Changes | 3 | 2006 | 16 | 0.140 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 2017 | 29 | 0.140 |
Why?
| Treatment Outcome | 2 | 2023 | 9088 | 0.140 |
Why?
| Neurocognitive Disorders | 1 | 1996 | 23 | 0.130 |
Why?
| Data Interpretation, Statistical | 1 | 1998 | 321 | 0.130 |
Why?
| Gene Expression | 5 | 2006 | 1421 | 0.130 |
Why?
| Skin Temperature | 2 | 2006 | 16 | 0.130 |
Why?
| Chewing Gum | 2 | 2007 | 8 | 0.130 |
Why?
| Prepulse Inhibition | 1 | 2015 | 9 | 0.130 |
Why?
| Benzodiazepines | 2 | 2008 | 116 | 0.130 |
Why?
| Cell Differentiation | 1 | 2002 | 1701 | 0.130 |
Why?
| Pandemics | 2 | 2021 | 1320 | 0.120 |
Why?
| Vanilmandelic Acid | 4 | 1990 | 4 | 0.120 |
Why?
| Nitric Oxide | 1 | 2000 | 823 | 0.120 |
Why?
| Methoxyhydroxyphenylglycol | 4 | 1990 | 11 | 0.120 |
Why?
| Respiratory Tract Infections | 1 | 2019 | 319 | 0.120 |
Why?
| Pneumonia, Viral | 1 | 2020 | 338 | 0.120 |
Why?
| Coronavirus Infections | 1 | 2020 | 330 | 0.120 |
Why?
| Cerebrovascular Circulation | 2 | 2007 | 221 | 0.120 |
Why?
| Hot Temperature | 2 | 2007 | 302 | 0.120 |
Why?
| Signal Processing, Computer-Assisted | 2 | 2013 | 133 | 0.120 |
Why?
| Postmenopause | 2 | 2007 | 303 | 0.120 |
Why?
| Snoring | 1 | 2014 | 12 | 0.120 |
Why?
| Twins | 1 | 1996 | 240 | 0.110 |
Why?
| Corpus Striatum | 2 | 1992 | 126 | 0.110 |
Why?
| Synapsins | 1 | 1993 | 12 | 0.110 |
Why?
| Synaptophysin | 1 | 1993 | 11 | 0.110 |
Why?
| Clonidine | 1 | 2013 | 22 | 0.110 |
Why?
| Polymorphism, Single-Stranded Conformational | 2 | 2003 | 25 | 0.110 |
Why?
| Sleep Stages | 1 | 1993 | 61 | 0.110 |
Why?
| Polymorphism, Genetic | 4 | 2009 | 610 | 0.110 |
Why?
| United States | 3 | 2018 | 12186 | 0.110 |
Why?
| Genomics | 1 | 2018 | 635 | 0.110 |
Why?
| Brain Tissue Transplantation | 1 | 1992 | 19 | 0.100 |
Why?
| Zinc | 1 | 1995 | 260 | 0.100 |
Why?
| Fetal Tissue Transplantation | 1 | 1992 | 35 | 0.100 |
Why?
| gamma-Aminobutyric Acid | 3 | 2003 | 144 | 0.100 |
Why?
| Perinatal Care | 1 | 2013 | 36 | 0.100 |
Why?
| Inflammation | 2 | 2021 | 2480 | 0.100 |
Why?
| Circadian Rhythm | 2 | 2013 | 356 | 0.100 |
Why?
| Heart Rate | 2 | 2007 | 709 | 0.100 |
Why?
| Pregnancy Complications | 2 | 2019 | 429 | 0.100 |
Why?
| Mesencephalon | 1 | 1992 | 57 | 0.100 |
Why?
| Stress, Psychological | 1 | 2020 | 944 | 0.100 |
Why?
| Estrogen Replacement Therapy | 1 | 2013 | 116 | 0.100 |
Why?
| Severity of Illness Index | 3 | 2015 | 2540 | 0.100 |
Why?
| Functional Laterality | 1 | 2013 | 198 | 0.100 |
Why?
| Parasympathetic Nervous System | 1 | 1992 | 24 | 0.100 |
Why?
| Auditory Pathways | 1 | 1992 | 53 | 0.100 |
Why?
| Immunity | 1 | 2013 | 121 | 0.100 |
Why?
| Iodine Radioisotopes | 4 | 2001 | 125 | 0.100 |
Why?
| Gene Frequency | 2 | 2005 | 477 | 0.100 |
Why?
| Blood Pressure | 3 | 2007 | 1538 | 0.100 |
Why?
| Memory | 1 | 2013 | 211 | 0.100 |
Why?
| Gene Duplication | 3 | 2015 | 62 | 0.090 |
Why?
| Synaptic Transmission | 5 | 1999 | 227 | 0.090 |
Why?
| Sleep Apnea, Obstructive | 1 | 2014 | 196 | 0.090 |
Why?
| Case-Control Studies | 4 | 2012 | 3003 | 0.090 |
Why?
| Aged | 9 | 2015 | 19074 | 0.090 |
Why?
| Genetic Association Studies | 1 | 2012 | 339 | 0.090 |
Why?
| Anxiety Disorders | 1 | 2012 | 303 | 0.080 |
Why?
| Electrophysiology | 5 | 1996 | 201 | 0.080 |
Why?
| Education, Distance | 1 | 2009 | 38 | 0.080 |
Why?
| Electromyography | 2 | 2005 | 326 | 0.080 |
Why?
| Alprazolam | 1 | 1988 | 6 | 0.080 |
Why?
| Sequence Deletion | 1 | 2009 | 167 | 0.080 |
Why?
| Follow-Up Studies | 2 | 2013 | 4411 | 0.080 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 4410 | 0.080 |
Why?
| Field Dependence-Independence | 1 | 2008 | 3 | 0.080 |
Why?
| Diazepam | 1 | 1988 | 25 | 0.080 |
Why?
| Lorazepam | 1 | 1988 | 23 | 0.080 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 81 | 0.080 |
Why?
| Quality Improvement | 1 | 2016 | 950 | 0.080 |
Why?
| Brief Psychiatric Rating Scale | 1 | 2008 | 4 | 0.080 |
Why?
| Parkinson Disease | 1 | 1992 | 345 | 0.080 |
Why?
| Rats, Inbred Strains | 6 | 1992 | 362 | 0.080 |
Why?
| Glycols | 1 | 1988 | 4 | 0.080 |
Why?
| Prospective Studies | 1 | 2019 | 6220 | 0.080 |
Why?
| Evoked Potentials, Somatosensory | 1 | 1988 | 31 | 0.070 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2013 | 1214 | 0.070 |
Why?
| Auditory Perceptual Disorders | 2 | 2008 | 8 | 0.070 |
Why?
| Genes | 2 | 1998 | 223 | 0.070 |
Why?
| Models, Neurological | 2 | 2000 | 212 | 0.070 |
Why?
| Microsatellite Repeats | 2 | 2012 | 137 | 0.070 |
Why?
| Time Factors | 3 | 2005 | 6116 | 0.070 |
Why?
| Auditory Cortex | 1 | 2007 | 40 | 0.070 |
Why?
| Depressive Disorder | 1 | 1990 | 332 | 0.070 |
Why?
| Diseases in Twins | 1 | 1988 | 174 | 0.070 |
Why?
| Alcoholism | 2 | 1995 | 713 | 0.070 |
Why?
| Monitoring, Ambulatory | 1 | 2007 | 81 | 0.070 |
Why?
| Cerebellum | 4 | 1988 | 200 | 0.070 |
Why?
| Sensitivity and Specificity | 2 | 2007 | 1694 | 0.060 |
Why?
| Drug Administration Schedule | 1 | 2008 | 718 | 0.060 |
Why?
| Telemetry | 1 | 2005 | 36 | 0.060 |
Why?
| Genome | 2 | 2006 | 271 | 0.060 |
Why?
| Memory, Short-Term | 1 | 2008 | 225 | 0.060 |
Why?
| Cold Temperature | 1 | 2006 | 126 | 0.060 |
Why?
| Menstrual Cycle | 1 | 2006 | 108 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2007 | 1796 | 0.060 |
Why?
| Sequence Analysis, DNA | 3 | 2003 | 723 | 0.060 |
Why?
| Internet | 1 | 2009 | 596 | 0.060 |
Why?
| Visual Pathways | 1 | 2005 | 44 | 0.060 |
Why?
| Parietal Lobe | 1 | 2005 | 41 | 0.060 |
Why?
| Mice | 6 | 2009 | 14872 | 0.060 |
Why?
| Quetiapine Fumarate | 1 | 2004 | 22 | 0.060 |
Why?
| Dibenzothiazepines | 1 | 2004 | 17 | 0.060 |
Why?
| Risperidone | 1 | 2004 | 26 | 0.060 |
Why?
| Statistics as Topic | 1 | 2005 | 292 | 0.060 |
Why?
| Verbal Behavior | 1 | 2004 | 43 | 0.060 |
Why?
| Area Under Curve | 1 | 2005 | 274 | 0.060 |
Why?
| Dopamine D2 Receptor Antagonists | 1 | 2003 | 5 | 0.060 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 180 | 0.060 |
Why?
| Dopamine Antagonists | 1 | 2003 | 22 | 0.060 |
Why?
| Visual Fields | 1 | 2004 | 77 | 0.060 |
Why?
| Early Diagnosis | 1 | 2005 | 217 | 0.060 |
Why?
| Single-Blind Method | 1 | 2004 | 258 | 0.050 |
Why?
| Mental Recall | 2 | 1996 | 171 | 0.050 |
Why?
| Pain Measurement | 1 | 2005 | 444 | 0.050 |
Why?
| Administration, Oral | 1 | 2005 | 728 | 0.050 |
Why?
| Action Potentials | 6 | 1993 | 406 | 0.050 |
Why?
| Head | 1 | 2004 | 85 | 0.050 |
Why?
| Age of Onset | 2 | 2007 | 446 | 0.050 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 230 | 0.050 |
Why?
| Oxygen Consumption | 1 | 2005 | 588 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2006 | 529 | 0.050 |
Why?
| Sex Characteristics | 1 | 2007 | 641 | 0.050 |
Why?
| Purkinje Cells | 5 | 1988 | 66 | 0.050 |
Why?
| Exons | 3 | 2015 | 302 | 0.050 |
Why?
| Chromosome Disorders | 2 | 1999 | 35 | 0.050 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2001 | 13 | 0.050 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2001 | 16 | 0.050 |
Why?
| Radioligand Assay | 1 | 2001 | 43 | 0.050 |
Why?
| Lod Score | 1 | 2001 | 65 | 0.050 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2001 | 18 | 0.050 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2001 | 43 | 0.050 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2001 | 65 | 0.050 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2001 | 56 | 0.050 |
Why?
| Cloning, Molecular | 2 | 2000 | 522 | 0.050 |
Why?
| Chromosome Aberrations | 2 | 1999 | 135 | 0.050 |
Why?
| Movement | 1 | 2004 | 244 | 0.050 |
Why?
| Binding, Competitive | 1 | 2001 | 193 | 0.050 |
Why?
| Hallucinations | 1 | 2001 | 30 | 0.050 |
Why?
| Cell Count | 1 | 2001 | 303 | 0.050 |
Why?
| Lymphocytes | 1 | 2002 | 330 | 0.050 |
Why?
| Nutritional Requirements | 1 | 2021 | 75 | 0.050 |
Why?
| Fornix, Brain | 1 | 2000 | 6 | 0.050 |
Why?
| Denervation | 1 | 2000 | 18 | 0.050 |
Why?
| Multifactorial Inheritance | 1 | 2001 | 122 | 0.040 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2000 | 38 | 0.040 |
Why?
| Point Mutation | 2 | 1999 | 216 | 0.040 |
Why?
| Family Health | 1 | 2001 | 193 | 0.040 |
Why?
| Animals, Newborn | 1 | 2002 | 778 | 0.040 |
Why?
| Algorithms | 1 | 2007 | 1470 | 0.040 |
Why?
| Blotting, Northern | 2 | 2005 | 193 | 0.040 |
Why?
| Blotting, Western | 3 | 2005 | 1147 | 0.040 |
Why?
| Binding Sites | 1 | 2002 | 1168 | 0.040 |
Why?
| Cocaine | 1 | 2001 | 153 | 0.040 |
Why?
| Genetic Testing | 1 | 2001 | 381 | 0.040 |
Why?
| Fathers | 1 | 1999 | 45 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 923 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 3 | 1989 | 470 | 0.040 |
Why?
| Event-Related Potentials, P300 | 1 | 1998 | 12 | 0.040 |
Why?
| Photic Stimulation | 1 | 1999 | 203 | 0.040 |
Why?
| Cell Movement | 1 | 2002 | 869 | 0.040 |
Why?
| Developmental Disabilities | 1 | 2021 | 237 | 0.040 |
Why?
| Self Medication | 1 | 1998 | 9 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 1998 | 106 | 0.040 |
Why?
| Cholinergic Agents | 1 | 1998 | 15 | 0.040 |
Why?
| Genetics, Population | 1 | 1999 | 188 | 0.040 |
Why?
| Heterozygote | 1 | 1998 | 251 | 0.040 |
Why?
| Parents | 2 | 2015 | 1186 | 0.040 |
Why?
| Electric Conductivity | 2 | 1998 | 88 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2001 | 1629 | 0.040 |
Why?
| Leukocytes, Mononuclear | 1 | 2000 | 493 | 0.040 |
Why?
| Conditioning, Classical | 2 | 2008 | 87 | 0.040 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 4 | 0.040 |
Why?
| Age Factors | 2 | 2006 | 2894 | 0.040 |
Why?
| Memory Disorders | 1 | 1998 | 155 | 0.030 |
Why?
| Electrooculography | 1 | 1996 | 10 | 0.030 |
Why?
| Base Sequence | 3 | 2009 | 2114 | 0.030 |
Why?
| In Situ Hybridization | 2 | 2013 | 292 | 0.030 |
Why?
| Risk | 1 | 1999 | 812 | 0.030 |
Why?
| Sensory Thresholds | 1 | 1996 | 28 | 0.030 |
Why?
| Motor Activity | 2 | 1992 | 640 | 0.030 |
Why?
| Surveys and Questionnaires | 1 | 2007 | 4624 | 0.030 |
Why?
| Nerve Fibers | 1 | 1995 | 87 | 0.030 |
Why?
| Placenta | 1 | 2021 | 628 | 0.030 |
Why?
| Receptors, Glutamate | 1 | 1995 | 18 | 0.030 |
Why?
| Nerve Net | 1 | 1998 | 226 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 1995 | 71 | 0.030 |
Why?
| Aging | 2 | 1999 | 1618 | 0.030 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 318 | 0.030 |
Why?
| Siblings | 1 | 2015 | 221 | 0.030 |
Why?
| Dyskinesia, Drug-Induced | 1 | 1994 | 11 | 0.030 |
Why?
| Chronic Disease | 1 | 1999 | 1578 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 1995 | 993 | 0.030 |
Why?
| Cholinergic Fibers | 1 | 1993 | 16 | 0.030 |
Why?
| Orientation | 1 | 1994 | 39 | 0.030 |
Why?
| Horseradish Peroxidase | 1 | 1993 | 24 | 0.030 |
Why?
| Neuromuscular Junction | 1 | 1994 | 53 | 0.030 |
Why?
| Genetic Engineering | 1 | 1994 | 80 | 0.030 |
Why?
| Peptides | 1 | 1999 | 848 | 0.030 |
Why?
| Gene Expression Profiling | 2 | 2013 | 1518 | 0.030 |
Why?
| Synaptic Vesicles | 1 | 1993 | 38 | 0.030 |
Why?
| Axonal Transport | 1 | 1993 | 21 | 0.030 |
Why?
| Temporal Lobe | 1 | 1993 | 79 | 0.030 |
Why?
| Habituation, Psychophysiologic | 1 | 1993 | 48 | 0.030 |
Why?
| Tissue Banks | 1 | 2013 | 17 | 0.030 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 49 | 0.030 |
Why?
| DNA Probes | 1 | 2013 | 59 | 0.030 |
Why?
| Nomifensine | 1 | 1992 | 3 | 0.030 |
Why?
| HLA-A Antigens | 1 | 2013 | 49 | 0.030 |
Why?
| Poly A | 1 | 1993 | 46 | 0.030 |
Why?
| Levodopa | 1 | 1992 | 23 | 0.030 |
Why?
| Receptors, sigma | 1 | 1992 | 1 | 0.030 |
Why?
| Genes, MHC Class I | 1 | 2013 | 32 | 0.030 |
Why?
| Biogenic Monoamines | 1 | 1992 | 13 | 0.030 |
Why?
| Tomography, Emission-Computed | 1 | 1992 | 58 | 0.030 |
Why?
| Benzylamines | 1 | 1992 | 39 | 0.030 |
Why?
| Tubocurarine | 1 | 1992 | 4 | 0.030 |
Why?
| N-Methylaspartate | 1 | 1992 | 37 | 0.030 |
Why?
| Mecamylamine | 1 | 1992 | 7 | 0.030 |
Why?
| Parasympatholytics | 1 | 1992 | 13 | 0.030 |
Why?
| Sympathomimetics | 1 | 1992 | 25 | 0.030 |
Why?
| Muscles | 1 | 1994 | 320 | 0.030 |
Why?
| Wakefulness | 1 | 1993 | 128 | 0.030 |
Why?
| Injections, Intraventricular | 1 | 1992 | 71 | 0.030 |
Why?
| Nervous System | 1 | 1992 | 63 | 0.030 |
Why?
| Microelectrodes | 1 | 1992 | 32 | 0.030 |
Why?
| Temperature | 1 | 1995 | 565 | 0.030 |
Why?
| Physical Chromosome Mapping | 1 | 2012 | 16 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 314 | 0.020 |
Why?
| Genotyping Techniques | 1 | 2012 | 69 | 0.020 |
Why?
| Transcription, Genetic | 1 | 1997 | 1313 | 0.020 |
Why?
| DNA Replication | 1 | 1993 | 202 | 0.020 |
Why?
| RNA | 2 | 2013 | 809 | 0.020 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 1994 | 333 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 1993 | 387 | 0.020 |
Why?
| Recombinant Proteins | 1 | 1994 | 1230 | 0.020 |
Why?
| Risk Assessment | 1 | 1999 | 2968 | 0.020 |
Why?
| Introns | 2 | 2003 | 227 | 0.020 |
Why?
| Molecular Sequence Data | 3 | 2003 | 2785 | 0.020 |
Why?
| Saccharomyces cerevisiae | 1 | 1994 | 476 | 0.020 |
Why?
| Adenylate Cyclase Toxin | 1 | 1989 | 8 | 0.020 |
Why?
| Virulence Factors, Bordetella | 1 | 1989 | 19 | 0.020 |
Why?
| Receptors, Dopamine | 1 | 1989 | 12 | 0.020 |
Why?
| Pertussis Toxin | 1 | 1989 | 26 | 0.020 |
Why?
| Blotting, Southern | 1 | 2009 | 68 | 0.020 |
Why?
| Autoanalysis | 1 | 1989 | 6 | 0.020 |
Why?
| Adenylyl Cyclases | 1 | 1989 | 83 | 0.020 |
Why?
| Odds Ratio | 1 | 2012 | 953 | 0.020 |
Why?
| Electrochemistry | 1 | 1989 | 79 | 0.020 |
Why?
| Cell Line | 2 | 2009 | 2637 | 0.020 |
Why?
| Yohimbine | 1 | 1988 | 9 | 0.020 |
Why?
| Dioxins | 1 | 1988 | 4 | 0.020 |
Why?
| Dioxanes | 1 | 1988 | 5 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 1989 | 139 | 0.020 |
Why?
| Gene Dosage | 1 | 2009 | 129 | 0.020 |
Why?
| Dihydro-beta-Erythroidine | 1 | 2008 | 3 | 0.020 |
Why?
| Receptors, Adrenergic | 1 | 1988 | 35 | 0.020 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2009 | 309 | 0.020 |
Why?
| Tyramine | 1 | 1988 | 10 | 0.020 |
Why?
| Pulse | 1 | 1988 | 27 | 0.020 |
Why?
| Saliva | 1 | 1989 | 188 | 0.020 |
Why?
| Fluphenazine | 1 | 1987 | 5 | 0.020 |
Why?
| Tobacco Use Disorder | 1 | 2010 | 234 | 0.020 |
Why?
| Mutation | 2 | 2015 | 3346 | 0.020 |
Why?
| Stereoisomerism | 1 | 1987 | 91 | 0.020 |
Why?
| Audiometry, Evoked Response | 1 | 1987 | 15 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 385 | 0.020 |
Why?
| Autoradiography | 2 | 1997 | 70 | 0.020 |
Why?
| Tyrosine | 1 | 1988 | 214 | 0.020 |
Why?
| Drug Interactions | 1 | 2008 | 338 | 0.020 |
Why?
| Suicide | 1 | 1993 | 508 | 0.020 |
Why?
| Depressive Disorder, Major | 1 | 2010 | 301 | 0.020 |
Why?
| Task Performance and Analysis | 1 | 2007 | 159 | 0.020 |
Why?
| Transcription Factors | 1 | 1994 | 1528 | 0.020 |
Why?
| ROC Curve | 1 | 2007 | 442 | 0.020 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2006 | 24 | 0.020 |
Why?
| alpha Catenin | 1 | 2005 | 13 | 0.020 |
Why?
| Patient Selection | 1 | 2009 | 641 | 0.020 |
Why?
| Microarray Analysis | 1 | 2005 | 118 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 511 | 0.020 |
Why?
| Nervous System Diseases | 1 | 1987 | 256 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 2007 | 1342 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1177 | 0.010 |
Why?
| Fourier Analysis | 1 | 2002 | 39 | 0.010 |
Why?
| Artifacts | 1 | 2002 | 114 | 0.010 |
Why?
| Sex Factors | 1 | 2006 | 1715 | 0.010 |
Why?
| Diet | 1 | 1988 | 1080 | 0.010 |
Why?
| Contig Mapping | 1 | 1998 | 10 | 0.010 |
Why?
| Genes, Duplicate | 1 | 1998 | 4 | 0.010 |
Why?
| Restriction Mapping | 1 | 1998 | 77 | 0.010 |
Why?
| Models, Biological | 1 | 2005 | 1621 | 0.010 |
Why?
| Receptors, Presynaptic | 1 | 1998 | 5 | 0.010 |
Why?
| Macaca radiata | 1 | 1997 | 16 | 0.010 |
Why?
| Autopsy | 1 | 1997 | 84 | 0.010 |
Why?
| Organ Specificity | 1 | 1997 | 268 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1996 | 396 | 0.010 |
Why?
| Species Specificity | 1 | 1996 | 542 | 0.010 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 1995 | 35 | 0.010 |
Why?
| Gene Amplification | 1 | 1995 | 95 | 0.010 |
Why?
| tau Proteins | 1 | 1995 | 66 | 0.010 |
Why?
| Isomerases | 1 | 1994 | 8 | 0.010 |
Why?
| Protein Disulfide-Isomerases | 1 | 1994 | 8 | 0.010 |
Why?
| Genes, Fungal | 1 | 1994 | 49 | 0.010 |
Why?
| Endopeptidases | 1 | 1994 | 71 | 0.010 |
Why?
| DNA Primers | 1 | 1995 | 510 | 0.010 |
Why?
| Glycosylation | 1 | 1994 | 130 | 0.010 |
Why?
| Molecular Biology | 1 | 1994 | 56 | 0.010 |
Why?
| Cadaver | 1 | 1995 | 299 | 0.010 |
Why?
| Fungal Proteins | 1 | 1994 | 119 | 0.010 |
Why?
| Genetic Vectors | 1 | 1994 | 289 | 0.010 |
Why?
| DNA | 1 | 1998 | 1352 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 1994 | 1982 | 0.010 |
Why?
| Idazoxan | 1 | 1988 | 1 | 0.000 |
Why?
| Phentolamine | 1 | 1988 | 14 | 0.000 |
Why?
| Receptors, Adrenergic, alpha | 1 | 1988 | 28 | 0.000 |
Why?
| Rats, Inbred F344 | 1 | 1988 | 241 | 0.000 |
Why?
| Desipramine | 1 | 1988 | 9 | 0.000 |
Why?
| Receptors, Adrenergic, beta | 1 | 1988 | 127 | 0.000 |
Why?
| DNA-Binding Proteins | 1 | 1994 | 1314 | 0.000 |
Why?
| Magnesium | 1 | 1987 | 145 | 0.000 |
Why?
| Aged, 80 and over | 1 | 1995 | 6347 | 0.000 |
Why?
|
|
Freedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|